Literature DB >> 17929147

Microencapsulation of PEGylated adenovirus within PLGA microspheres for enhanced stability and gene transfection efficiency.

Hyejung Mok1, Ji Won Park, Tae Gwan Park.   

Abstract

PURPOSE: Green fluorescent protein (GFP) encoding adenovirus (ADV) was surface modified with polyethylene glycol (PEG) for microencapsulation within poly(lactic-co-glycolic acid) (PLGA) microspheres with the aim of improving stability and gene transfection activity.
METHODS: A series of PEGylated ADV (PEG-ADV) with different PEG seeding densities on the viral surface was prepared and the GFP expression efficiency of each PEG-ADV in the series determined. The physical stabilities of naked ADV and PEG-ADV were comparatively evaluated by exerting a high shear homogenization process or by exposure to low pH. Naked ADV or PEG-ADV was microencapsulated within PLGA microspheres using a water-in-oil-in-water (W/O/W) double emulsion and solvent evaporation method. In vitro cumulative ADV and PEG-ADV release profiles from PLGA microspheres were determined over a 10-day period. GFP transfection efficiencies into HeLa cells were quantified, and the relative extent of the immune response for ADV and PEG-ADV encapsulated within PLGA microspheres was analyzed using macrophage cells.
RESULTS: The physical stability of PEGylated ADV was greatly enhanced relative to that of naked ADV under the simulated W/O/W formulation conditions, such as exposure to an aqueous/organic interface during high shear-stressed homogenization. PEG-ADV was also more stable than ADV at low pH. ADV and PEG-AD were both released from PLGA microspheres similarly in a sustained fashion. However, when the ADV and PEG-ADV encapsulated microspheres transfected into HeLa cells, PEG-ADV microspheres demonstrated a higher GFP gene transfection efficiency than ADV microspheres. The PEG-ADV microspheres also exhibited a reduced extent of innate immune response for macrophage cells.
CONCLUSIONS: PEGylated ADV could be more safely microencapsulated within PLGA microspheres than naked ADV due to their enhanced physical stability under the harsh formulation conditions and acidic microenvironmental conditions of the microsphere, thereby increasing gene transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17929147     DOI: 10.1007/s11095-007-9441-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  34 in total

1.  Quantitation of adenovirus DNA and virus particles with the PicoGreen fluorescent Dye.

Authors:  P Murakami; M T McCaman
Journal:  Anal Biochem       Date:  1999-10-15       Impact factor: 3.365

2.  Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.

Authors:  Hong Kee Kim; Tae Gwan Park
Journal:  J Control Release       Date:  2004-07-23       Impact factor: 9.776

Review 3.  Targeted adenovirus vectors.

Authors:  Hiroyuki Mizuguchi; Takao Hayakawa
Journal:  Hum Gene Ther       Date:  2004-11       Impact factor: 5.695

4.  Effect of high shear on proteins.

Authors:  Y F Maa; C C Hsu
Journal:  Biotechnol Bioeng       Date:  1996-08-20       Impact factor: 4.530

5.  Pegylation enhances protein stability during encapsulation in PLGA microspheres.

Authors:  M Diwan; T G Park
Journal:  J Control Release       Date:  2001-06-15       Impact factor: 9.776

6.  Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres.

Authors:  Tae Hyoung Kim; Haeshin Lee; Tae Gwan Park
Journal:  Biomaterials       Date:  2002-06       Impact factor: 12.479

7.  Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.

Authors:  Hoyin Mok; Donna J Palmer; Philip Ng; Michael A Barry
Journal:  Mol Ther       Date:  2005-01       Impact factor: 11.454

8.  Folate immobilized and PEGylated adenovirus for retargeting to tumor cells.

Authors:  In Kyung Oh; Hyejung Mok; Tae Gwan Park
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

9.  Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein.

Authors:  Fwu-Long Mi; Shin-Shing Shyu; Yi-Mei Lin; Yu-Bey Wu; Chih-Kang Peng; Yi-Hung Tsai
Journal:  Biomaterials       Date:  2003-12       Impact factor: 12.479

10.  A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.

Authors:  Ken-ichi Ogawara; Marianne G Rots; Robbert J Kok; Henk E Moorlag; Anne-Miek Van Loenen; Dirk K F Meijer; Hidde J Haisma; Grietje Molema
Journal:  Hum Gene Ther       Date:  2004-05       Impact factor: 5.695

View more
  12 in total

Review 1.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

Review 2.  Engineering biomaterial systems to enhance viral vector gene delivery.

Authors:  Jae-Hyung Jang; David V Schaffer; Lonnie D Shea
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

Review 3.  Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.

Authors:  Justin L Madrigal; Roberta Stilhano; Eduardo A Silva
Journal:  Tissue Eng Part B Rev       Date:  2017-03-10       Impact factor: 6.389

Review 4.  Adenoviral vector immunity: its implications and circumvention strategies.

Authors:  Yadvinder S Ahi; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2011-08       Impact factor: 4.391

5.  Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells.

Authors:  Michael Chorny; Ilia Fishbein; Ivan Alferiev; Robert J Levy
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

Review 6.  Hydrogels for lentiviral gene delivery.

Authors:  Stephanie K Seidlits; Robert Michael Gower; Jaclyn A Shepard; Lonnie D Shea
Journal:  Expert Opin Drug Deliv       Date:  2013-01-25       Impact factor: 6.648

7.  Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors.

Authors:  Michael Chorny; Ilia Fishbein; Jillian E Tengood; Richard F Adamo; Ivan S Alferiev; Robert J Levy
Journal:  FASEB J       Date:  2013-02-13       Impact factor: 5.191

Review 8.  Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics.

Authors:  Hyejung Mok; Miqin Zhang
Journal:  Expert Opin Drug Deliv       Date:  2012-12-01       Impact factor: 6.648

9.  PEGylated Adenoviruses: From Mice to Monkeys.

Authors:  Piyanuch Wonganan; Maria A Croyle
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.818

Review 10.  Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.

Authors:  Raquel Yokoda; Bolni M Nagalo; Brent Vernon; Rahmi Oklu; Hassan Albadawi; Thomas T DeLeon; Yumei Zhou; Jan B Egan; Dan G Duda; Mitesh J Borad
Journal:  Oncolytic Virother       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.